$HPK
HighPeak Energy, Inc. Stock $hpk

$hpk Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-Q Financial Statement

#000143774924015355 Filed on May 08, 2024

Income Statement

Concept	2024 Q2	2024 Q1	2023 Q1
Revenue	$275.3M	$287.8M	$223.8M
YoY Change	14.33%	28.58%	142.65%
Cost Of Revenue	$32.80M	$30.27M	$32.94M
YoY Change	-6.11%	-8.11%	248.74%
Gross Profit	$242.5M	$257.5M	$190.9M
YoY Change	17.8%	34.92%	130.54%
Gross Profit Margin	88.08%	89.48%	85.28%
Selling, General & Admin	$4.735M	$4.685M	$2.502M
YoY Change	88.2%	87.25%	28.97%
% of Gross Profit	1.95%	1.82%	1.31%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$127.7M	$130.9M	$81.13M
YoY Change	37.29%	61.28%	376.57%
% of Gross Profit	52.66%	50.82%	42.51%
Operating Expenses	$4.735M	$4.685M	$2.502M
YoY Change	88.2%	87.25%	28.97%
Operating Profit	$87.26M	$103.0M	$88.59M
YoY Change	2.71%	16.29%	62.32%
Interest Expense	$42.99M	$43.63M	$26.97M
YoY Change	9.44%	61.78%	413.56%
% of Operating Profit	49.27%	42.35%	30.45%
Other Income/Expense, Net	-$2.000M	$0.00	$0.00
YoY Change	-73.34%
Pretax Income	$43.97M	$8.735M	$64.76M
YoY Change	6.02%	-86.51%	-485.0%
Income Tax	$14.25M	$2.297M	$14.51M
% Of Pretax Income	32.41%	26.3%	22.4%
Net Earnings	$29.72M	$6.438M	$50.26M
YoY Change	-6.63%	-87.19%	-404.4%
Net Earnings / Revenue	10.8%	2.24%	22.46%
Basic Earnings Per Share	$0.21	$0.05	$0.41
Diluted Earnings Per Share	$0.21	$0.05	$0.39
COMMON SHARES
Basic Shares Outstanding	127.9M	128.4M	113.2M
Diluted Shares Outstanding	129.2M	129.6M	117.8M

Balance Sheet

Concept	2024 Q2	2024 Q1	2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$157.9M	$173.4M	$47.54M
YoY Change	421.76%	264.73%	32.6%
Cash & Equivalents	$157.9M	$173.4M	$47.54M
Short-Term Investments
Other Short-Term Assets	$5.351M	$5.411M	$1.004M
YoY Change	49.09%	438.94%	-93.36%
Inventory	$7.817M	$11.18M	$15.76M
Prepaid Expenses	$3.073M	$2.772M	$1.004M
Receivables	$87.56M	$109.0M	$80.98M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$258.6M	$299.0M	$145.3M
YoY Change	79.57%	105.79%	43.65%
LONG-TERM ASSETS
Property, Plant & Equipment	$3.518M	$3.563M	$3.556M
YoY Change	-2.06%	0.2%	117.23%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$6.577M	$5.116M	$7.067M
YoY Change	-2.87%	-27.61%	56.52%
Total Long-Term Assets	$2.798B	$2.756B	$2.437B
YoY Change	5.74%	13.07%	133.54%
TOTAL ASSETS
Total Short-Term Assets	$258.6M	$299.0M	$145.3M
Total Long-Term Assets	$2.798B	$2.756B	$2.437B
Total Assets	$3.056B	$3.055B	$2.583B
YoY Change	9.55%	18.28%	125.6%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$40.45M	$47.27M	$133.2M
YoY Change	-81.26%	-64.52%	125.6%
Accrued Expenses	$72.64M	$70.06M	$161.9M
YoY Change	-45.47%	-56.73%	178.75%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$120.0M	$120.0M	$215.3M
YoY Change	-83.81%	-44.26%
Total Short-Term Liabilities	$278.9M	$288.0M	$561.4M
YoY Change	-75.5%	-48.71%	212.52%
LONG-TERM LIABILITIES
Long-Term Debt	$979.3M	$1.005B	$645.5M
YoY Change	322.36%	55.67%	217.66%
Other Long-Term Liabilities	$14.85M	$14.74M	$8.960M
YoY Change	60.57%	64.5%	330.77%
Total Long-Term Liabilities	$979.3M	$1.005B	$645.5M
YoY Change	322.36%	55.67%	214.44%
TOTAL LIABILITIES
Total Short-Term Liabilities	$278.9M	$288.0M	$561.4M
Total Long-Term Liabilities	$979.3M	$1.005B	$645.5M
Total Liabilities	$1.258B	$1.293B	$1.207B
YoY Change	-8.17%	7.11%	213.54%
SHAREHOLDERS EQUITY
Retained Earnings	$388.1M	$364.1M	$207.9M
YoY Change	64.05%	75.13%	-348.57%
Common Stock	$13.00K	$13.00K	$11.00K
YoY Change	18.18%	18.18%	10.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$1.570B	$1.548B	$1.221B
YoY Change
Total Liabilities & Shareholders Equity	$3.056B	$3.055B	$2.583B
YoY Change	9.55%	18.28%	125.6%

Cashflow Statement

Concept	2024 Q2	2024 Q1	2023 Q1
OPERATING ACTIVITIES
Net Income	$29.72M	$6.438M	$50.26M
YoY Change	-6.63%	-87.19%	-404.4%
Depreciation, Depletion And Amortization	$127.7M	$130.9M	$81.13M
YoY Change	37.29%	61.28%	376.57%
Cash From Operating Activities	$202.3M	$171.4M	$190.0M
YoY Change	16.5%	-9.77%	280.42%
INVESTING ACTIVITIES
Capital Expenditures	$164.3M	$147.8M	$379.1M
YoY Change	-45.24%	-61.03%	-329.63%
Acquisitions
YoY Change
Other Investing Activities	-$12.13M	-$466.0K	$59.60M
YoY Change	-274.46%	-100.78%	319.71%
Cash From Investing Activities	-$176.4M	-$148.2M	-$319.5M
YoY Change	-39.8%	-53.61%	111.75%
FINANCING ACTIVITIES
Cash Dividend Paid		$5.050M	$2.776M
YoY Change		81.92%	16.54%
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-41.41M	-$44.35M	$146.5M
YoY Change	-140.58%	-130.26%	43.77%
NET CHANGE
Cash From Operating Activities	202.3M	$171.4M	$190.0M
Cash From Investing Activities	-176.4M	-$148.2M	-$319.5M
Cash From Financing Activities	-41.41M	-$44.35M	$146.5M
Net Change In Cash	-15.47M	-$21.14M	$17.03M
YoY Change	-10.43%	-224.09%	1636.19%
FREE CASH FLOW
Cash From Operating Activities	$202.3M	$171.4M	$190.0M
Capital Expenditures	$164.3M	$147.8M	$379.1M
Free Cash Flow	$38.07M	$23.68M	-$189.1M
YoY Change	-130.15%	-112.52%	-187.94%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	287764000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	50257000	usd
CY2023Q1	us-gaap	Payments Of Dividends PaymentsOfDividends	2776000	usd
CY2023Q1	hpk	Payments Of Dividends Equivalents PaymentsOfDividendsEquivalents	282000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	194515000	usd
CY2024Q1	us-gaap	Increase Decrease In Asset Retirement Obligations IncreaseDecreaseInAssetRetirementObligations	201000	usd
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	127855383
CY2024Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2024Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2024Q1	dei	Amendment Flag AmendmentFlag	false
CY2024Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001792849
CY2024Q1	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q1	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q1	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q1	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	0	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	0	usd
CY2023Q1	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	usd
CY2024Q1	hpk	Capitalized Exploratory Well Costs Maximum Term CapitalizedExploratoryWellCostsMaximumTerm	P1Y
CY2024Q1	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	pure
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	usd
CY2024Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	usd
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	128420923
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	128420923
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	223794000	usd
CY2024Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	30271000	usd
CY2023Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	32942000	usd
CY2024Q1	us-gaap	Production Tax Expense ProductionTaxExpense	14402000	usd
CY2024Q1	us-gaap	Exploration Expense ExplorationExpense	498000	usd
CY2023Q1	us-gaap	Exploration Expense ExplorationExpense	2164000	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	81131000	usd
CY2024Q1	us-gaap	Asset Retirement Obligation Accretion Expense AssetRetirementObligationAccretionExpense	239000	usd
CY2023Q1	us-gaap	Asset Retirement Obligation Accretion Expense AssetRetirementObligationAccretionExpense	118000	usd
CY2024Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	4685000	usd
CY2023Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2502000	usd
CY2024Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3798000	usd
CY2023Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	4054000	usd
CY2024Q1	us-gaap	Costs And Expenses CostsAndExpenses	184743000	usd
CY2023Q1	us-gaap	Costs And Expenses CostsAndExpenses	135208000	usd
CY2024Q1	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	1000	usd
CY2023Q1	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	0	usd
CY2024Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	103020000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	88586000	usd
CY2023Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	30000	usd
CY2024Q1	us-gaap	Interest Expense InterestExpense	43634000	usd
CY2024Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	8735000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	64764000	usd
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2297000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	14507000	usd
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	127855383
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	128420923
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	128420923
CY2024Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	30271000	usd
CY2024Q1	us-gaap	Production Tax Expense ProductionTaxExpense	14402000	usd
CY2023Q1	us-gaap	Production Tax Expense ProductionTaxExpense	12297000	usd
CY2024Q1	us-gaap	Exploration Expense ExplorationExpense	498000	usd
CY2023Q1	us-gaap	Exploration Expense ExplorationExpense	2164000	usd
CY2024Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	130850000	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	81131000	usd
CY2023Q1	us-gaap	Asset Retirement Obligation Accretion Expense AssetRetirementObligationAccretionExpense	118000	usd
CY2024Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	4685000	usd
CY2023Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2502000	usd
CY2024Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3798000	usd
CY2023Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	4054000	usd
CY2024Q1	us-gaap	Costs And Expenses CostsAndExpenses	184743000	usd
CY2023Q1	us-gaap	Costs And Expenses CostsAndExpenses	135208000	usd
CY2024Q1	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	1000	usd
CY2023Q1	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	0	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	88586000	usd
CY2024Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	2392000	usd
CY2023Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	30000	usd
CY2024Q1	us-gaap	Interest Expense InterestExpense	43634000	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	26972000	usd
CY2024Q1	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	-53043000	usd
CY2023Q1	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	3120000	usd
CY2024Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	8735000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	64764000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	14507000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	6438000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	6438000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	50257000	usd
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.05
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.41
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.05
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	125696000
CY2024Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.04
CY2023Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.025
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	1552721000	usd
CY2024Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.04
CY2024Q1	us-gaap	Dividends Cash DividendsCash	5137000	usd
CY2024Q1	hpk	Dividend Equivalents Per Share Declared DividendEquivalentsPerShareDeclared	0.04
CY2024Q1	hpk	Dividend Equivalents Cash DividendEquivalentsCash	532000	usd
CY2024Q1	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	8851000	usd
CY2024Q1	hpk	Stock Issued During Period Value Exercise Of Warrants StockIssuedDuringPeriodValueExerciseOfWarrants	0	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	0	usd
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	3798000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	6438000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	1548437000	usd
CY2023Q1	hpk	Stock Issued During Period Value Exercise Of Warrants StockIssuedDuringPeriodValueExerciseOfWarrants	2000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	148000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	1220991000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	50257000	usd
CY2023Q1	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	3120000	usd
CY2024Q1	hpk	Net Cash Receipts From Payments On Derivatives NetCashReceiptsFromPaymentsOnDerivatives	5148000	usd
CY2023Q1	hpk	Net Cash Receipts From Payments On Derivatives NetCashReceiptsFromPaymentsOnDerivatives	2194000	usd
CY2024Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	2453000	usd
CY2024Q1	us-gaap	Share Based Compensation ShareBasedCompensation	3798000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	4054000	usd
CY2024Q1	us-gaap	Accretion Expense Including Asset Retirement Obligations AccretionExpenseIncludingAssetRetirementObligations	239000	usd
CY2023Q1	us-gaap	Accretion Expense Including Asset Retirement Obligations AccretionExpenseIncludingAssetRetirementObligations	118000	usd
CY2024Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	130850000	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	81131000	usd
CY2024Q1	us-gaap	Exploration Abandonment And Impairment Expense ExplorationAbandonmentAndImpairmentExpense	274000	usd
CY2023Q1	us-gaap	Exploration Abandonment And Impairment Expense ExplorationAbandonmentAndImpairmentExpense	1950000	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	14414000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-15617000	usd
CY2024Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	4722000	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	2567000	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-5113000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	23295000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	171439000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	190006000	usd
CY2024Q1	us-gaap	Payments To Explore And Develop Oil And Gas Properties PaymentsToExploreAndDevelopOilAndGasProperties	147698000	usd
CY2023Q1	us-gaap	Payments To Explore And Develop Oil And Gas Properties PaymentsToExploreAndDevelopOilAndGasProperties	379103000	usd
CY2024Q1	hpk	Increase Decrease In Working Capital Associated With Oil And Natural Gas Property Additions IncreaseDecreaseInWorkingCapitalAssociatedWithOilAndNaturalGasPropertyAdditions	1705000	usd
CY2023Q1	hpk	Increase Decrease In Working Capital Associated With Oil And Natural Gas Property Additions IncreaseDecreaseInWorkingCapitalAssociatedWithOilAndNaturalGasPropertyAdditions	65062000	usd
CY2024Q1	us-gaap	Payments To Acquire Oil And Gas Property PaymentsToAcquireOilAndGasProperty	2171000	usd
CY2023Q1	us-gaap	Payments To Acquire Oil And Gas Property PaymentsToAcquireOilAndGasProperty	5463000	usd
CY2024Q1	us-gaap	Payments To Acquire Other Productive Assets PaymentsToAcquireOtherProductiveAssets	59000	usd
CY2023Q1	us-gaap	Payments To Acquire Other Productive Assets PaymentsToAcquireOtherProductiveAssets	18000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	171439000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	50257000	usd
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.05
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.41
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.05
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.39
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	125696000
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	111055000
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	129641000
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	117765000
CY2024Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.04
CY2023Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.025
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	1552721000	usd
CY2024Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.04
CY2024Q1	us-gaap	Dividends Cash DividendsCash	5137000	usd
CY2024Q1	hpk	Dividend Equivalents Per Share Declared DividendEquivalentsPerShareDeclared	0.04
CY2024Q1	hpk	Dividend Equivalents Cash DividendEquivalentsCash	532000	usd
CY2024Q1	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	8851000	usd
CY2024Q1	hpk	Stock Issued During Period Value Exercise Of Warrants StockIssuedDuringPeriodValueExerciseOfWarrants	0	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	0	usd
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	3798000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	6438000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	1548437000	usd
CY2023Q1	us-gaap	Dividends Cash DividendsCash	2829000	usd
CY2023Q1	hpk	Dividend Equivalents Per Share Declared DividendEquivalentsPerShareDeclared	0.025
CY2023Q1	hpk	Dividend Equivalents Cash DividendEquivalentsCash	288000	usd
CY2023Q1	hpk	Stock Issued During Period Value Exercise Of Warrants StockIssuedDuringPeriodValueExerciseOfWarrants	2000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	148000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	4054000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	6438000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	50257000	usd
CY2024Q1	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	-1688000	usd
CY2023Q1	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	-14507000	usd
CY2024Q1	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-53043000	usd
CY2023Q1	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	3120000	usd
CY2024Q1	hpk	Net Cash Receipts From Payments On Derivatives NetCashReceiptsFromPaymentsOnDerivatives	5148000	usd
CY2023Q1	hpk	Net Cash Receipts From Payments On Derivatives NetCashReceiptsFromPaymentsOnDerivatives	2194000	usd
CY2024Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	2053000	usd
CY2023Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	2668000	usd
CY2024Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	2453000	usd
CY2023Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	4290000	usd
CY2024Q1	us-gaap	Share Based Compensation ShareBasedCompensation	3798000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	4054000	usd
CY2024Q1	us-gaap	Accretion Expense Including Asset Retirement Obligations AccretionExpenseIncludingAssetRetirementObligations	239000	usd
CY2024Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	130850000	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	81131000	usd
CY2024Q1	us-gaap	Exploration Abandonment And Impairment Expense ExplorationAbandonmentAndImpairmentExpense	274000	usd
CY2023Q1	us-gaap	Exploration Abandonment And Impairment Expense ExplorationAbandonmentAndImpairmentExpense	1950000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-15617000	usd
CY2024Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	4722000	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	2567000	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-5113000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	23295000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	190006000	usd
CY2024Q1	us-gaap	Payments To Explore And Develop Oil And Gas Properties PaymentsToExploreAndDevelopOilAndGasProperties	147698000	usd
CY2023Q1	us-gaap	Payments To Explore And Develop Oil And Gas Properties PaymentsToExploreAndDevelopOilAndGasProperties	379103000	usd
CY2024Q1	hpk	Increase Decrease In Working Capital Associated With Oil And Natural Gas Property Additions IncreaseDecreaseInWorkingCapitalAssociatedWithOilAndNaturalGasPropertyAdditions	1705000	usd
CY2023Q1	hpk	Increase Decrease In Working Capital Associated With Oil And Natural Gas Property Additions IncreaseDecreaseInWorkingCapitalAssociatedWithOilAndNaturalGasPropertyAdditions	65062000	usd
CY2024Q1	us-gaap	Payments To Acquire Oil And Gas Property PaymentsToAcquireOilAndGasProperty	2171000	usd
CY2023Q1	us-gaap	Payments To Acquire Oil And Gas Property PaymentsToAcquireOilAndGasProperty	5463000	usd
CY2024Q1	us-gaap	Payments To Acquire Other Productive Assets PaymentsToAcquireOtherProductiveAssets	59000	usd
CY2023Q1	us-gaap	Payments To Acquire Other Productive Assets PaymentsToAcquireOtherProductiveAssets	18000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-148223000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-319522000	usd
CY2024Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	8764000	usd
CY2023Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	-0	usd
CY2024Q1	us-gaap	Payments Of Dividends PaymentsOfDividends	5050000	usd
CY2024Q1	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	7000	usd
CY2023Q1	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	544000	usd
CY2024Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0	usd
CY2023Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	148000	usd
CY2024Q1	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	0	usd
CY2023Q1	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	2000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-44351000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	146548000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	17032000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	30504000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	173380000	usd
CY2024Q1	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	usd
CY2023Q1	us-gaap	Increase Decrease In Asset Retirement Obligations IncreaseDecreaseInAssetRetirementObligations	768000	usd
CY2024Q1	us-gaap	Use Of Estimates UseOfEstimates	<b><i>Use of estimates in the preparation of financial statements. </i></b>Preparation of the Company's condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities as of the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting periods. Depletion of crude oil and natural gas properties is determined using estimates of proved crude oil, NGL and natural gas reserves and evaluations for impairment of proved and unproved crude oil and natural gas properties, in part, is determined using estimates of proved and risk adjusted probable and possible crude oil, NGL and natural gas reserves. There are numerous uncertainties inherent in the estimation of quantities of proved, probable and possible reserves and in the projection of future rates of production and the timing of development expenditures. Similarly, if needed, evaluations for impairment of proved crude oil and natural gas properties are subject to numerous uncertainties including, among others, estimates of future recoverable reserves, commodity price outlooks and future undiscounted and discounted net cash flows. In addition, evaluations for impairment of unproved crude oil and natural gas properties on a project-by-project basis are also subject to numerous uncertainties including, among others, estimates of future recoverable reserves, results of exploration activities, commodity price outlooks, planned future sales or expirations of all or a portion of such projects. Other items subject to such estimates and assumptions include, but are not limited to, the carrying value of crude oil and natural gas properties, asset retirement obligations, equity-based compensation, fair value of derivatives, expected credit losses and estimates of income taxes. Actual results could differ from the estimates and assumptions utilized.
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-319522000	usd
CY2024Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	8764000	usd
CY2023Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	-0	usd
CY2024Q1	us-gaap	Payments Of Dividends PaymentsOfDividends	5050000	usd
CY2024Q1	hpk	Payments Of Dividends Equivalents PaymentsOfDividendsEquivalents	530000	usd
CY2024Q1	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	7000	usd
CY2023Q1	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	544000	usd
CY2023Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	148000	usd
CY2023Q1	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	2000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-21135000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	17032000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	47536000	usd
CY2024Q1	us-gaap	Interest Paid Net InterestPaidNet	39678000	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	18078000	usd
CY2024Q1	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	usd
CY2023Q1	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	usd
CY2023Q1	us-gaap	Increase Decrease In Asset Retirement Obligations IncreaseDecreaseInAssetRetirementObligations	768000	usd
CY2024Q1	us-gaap	Use Of Estimates UseOfEstimates	<b><i>Use of estimates in the preparation of financial statements. </i></b>Preparation of the Company's condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities as of the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting periods. Depletion of crude oil and natural gas properties is determined using estimates of proved crude oil, NGL and natural gas reserves and evaluations for impairment of proved and unproved crude oil and natural gas properties, in part, is determined using estimates of proved and risk adjusted probable and possible crude oil, NGL and natural gas reserves. There are numerous uncertainties inherent in the estimation of quantities of proved, probable and possible reserves and in the projection of future rates of production and the timing of development expenditures. Similarly, if needed, evaluations for impairment of proved crude oil and natural gas properties are subject to numerous uncertainties including, among others, estimates of future recoverable reserves, commodity price outlooks and future undiscounted and discounted net cash flows. In addition, evaluations for impairment of unproved crude oil and natural gas properties on a project-by-project basis are also subject to numerous uncertainties including, among others, estimates of future recoverable reserves, results of exploration activities, commodity price outlooks, planned future sales or expirations of all or a portion of such projects. Other items subject to such estimates and assumptions include, but are not limited to, the carrying value of crude oil and natural gas properties, asset retirement obligations, equity-based compensation, fair value of derivatives, expected credit losses and estimates of income taxes. Actual results could differ from the estimates and assumptions utilized.
CY2024Q1	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet	-47895000	usd
CY2024Q1	us-gaap	Oil And Gas Joint Interest Billing Receivables OilAndGasJointInterestBillingReceivables	6400000	usd
CY2023Q4	us-gaap	Oil And Gas Joint Interest Billing Receivables OilAndGasJointInterestBillingReceivables	4400000	usd
CY2024Q1	us-gaap	Income Tax Receivable IncomeTaxReceivable	2800000	usd
CY2023Q4	us-gaap	Income Tax Receivable IncomeTaxReceivable	3200000	usd
CY2024Q1	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<b><i>Concentration of credit risk. </i></b>The Company is subject to credit risk resulting from the concentration of its crude oil and natural gas receivables with significant purchasers. For the three months ended March 31, 2024 and the year ended December 31, 2023, sales to the Company’s largest purchaser accounted for approximately 76% and 82%, respectively, and sales to the Company’s second largest purchaser accounted for approximately 17% and 14%, respectively, of the Company’s total crude oil, NGL and natural gas sales revenues. The Company generally does not require collateral and does not believe the loss of these particular purchasers would materially impact its operating results, as crude oil and natural gas are fungible products with well-established markets and numerous purchasers in various regions.
CY2023Q4	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	7300000	usd
CY2024Q1	us-gaap	Prepaid Expense Current And Noncurrent PrepaidExpenseCurrentAndNoncurrent	2800000	usd
CY2023Q4	us-gaap	Prepaid Expense Current And Noncurrent PrepaidExpenseCurrentAndNoncurrent	1000000	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3563000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3572000	usd
CY2024Q1	us-gaap	Oil And Gas Joint Interest Billing Receivables OilAndGasJointInterestBillingReceivables	6400000	usd
CY2023Q4	us-gaap	Oil And Gas Joint Interest Billing Receivables OilAndGasJointInterestBillingReceivables	4400000	usd
CY2024Q1	us-gaap	Income Tax Receivable IncomeTaxReceivable	2800000	usd
CY2023Q4	us-gaap	Income Tax Receivable IncomeTaxReceivable	3200000	usd
CY2024Q1	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<b><i>Concentration of credit risk. </i></b>The Company is subject to credit risk resulting from the concentration of its crude oil and natural gas receivables with significant purchasers. For the three months ended March 31, 2024 and the year ended December 31, 2023, sales to the Company’s largest purchaser accounted for approximately 76% and 82%, respectively, and sales to the Company’s second largest purchaser accounted for approximately 17% and 14%, respectively, of the Company’s total crude oil, NGL and natural gas sales revenues. The Company generally does not require collateral and does not believe the loss of these particular purchasers would materially impact its operating results, as crude oil and natural gas are fungible products with well-established markets and numerous purchasers in various regions.
CY2024Q1	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	11200000	usd
CY2023Q4	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	7300000	usd
CY2024Q1	us-gaap	Prepaid Expense Current And Noncurrent PrepaidExpenseCurrentAndNoncurrent	2800000	usd
CY2023Q4	us-gaap	Prepaid Expense Current And Noncurrent PrepaidExpenseCurrentAndNoncurrent	1000000	usd
CY2024Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	935000000000	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	904000000000	usd
CY2023Q1	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet	5314000	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3563000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3572000	usd
CY2024Q1	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	288000000	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	287400000	usd
CY2024Q1	us-gaap	Payments To Acquire Oil And Gas Property And Equipment PaymentsToAcquireOilAndGasPropertyAndEquipment	2200000	usd
CY2023Q1	us-gaap	Payments To Acquire Oil And Gas Property And Equipment PaymentsToAcquireOilAndGasPropertyAndEquipment	5500000	usd
CY2024Q1	us-gaap	Payments To Acquire Oil And Gas Property And Equipment PaymentsToAcquireOilAndGasPropertyAndEquipment	2200000	usd
CY2023Q1	us-gaap	Payments To Acquire Oil And Gas Property And Equipment PaymentsToAcquireOilAndGasPropertyAndEquipment	5500000	usd
CY2024Q1	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet	-47895000	usd
CY2023Q1	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet	5314000	usd
CY2024Q1	hpk	Net Cash Receipts From Payments On Derivatives NetCashReceiptsFromPaymentsOnDerivatives	5148000	usd
CY2023Q1	hpk	Net Cash Receipts From Payments On Derivatives NetCashReceiptsFromPaymentsOnDerivatives	2194000	usd
CY2024Q1	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-53043000	usd
CY2023Q1	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	3120000	usd
CY2024Q1	hpk	Net Cash Receipts From Payments On Derivatives NetCashReceiptsFromPaymentsOnDerivatives	5148000	usd
CY2023Q1	hpk	Net Cash Receipts From Payments On Derivatives NetCashReceiptsFromPaymentsOnDerivatives	2194000	usd
CY2024Q1	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-53043000	usd
CY2023Q1	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	3120000	usd
CY2023Q4	us-gaap	Capitalized Exploratory Well Costs CapitalizedExploratoryWellCosts	40888000	usd
CY2024Q1	us-gaap	Capitalized Exploratory Well Cost Additions Pending Determination Of Proved Reserves CapitalizedExploratoryWellCostAdditionsPendingDeterminationOfProvedReserves	25818000	usd
CY2024Q1	us-gaap	Reclassification To Well Facilities And Equipment Based On Determination Of Proved Reserves ReclassificationToWellFacilitiesAndEquipmentBasedOnDeterminationOfProvedReserves	41299000	usd
CY2024Q1	us-gaap	Capitalized Exploratory Well Cost Charged To Expense1 CapitalizedExploratoryWellCostChargedToExpense1	229000	usd
CY2024Q1	us-gaap	Capitalized Exploratory Well Costs CapitalizedExploratoryWellCosts	25178000	usd
CY2024Q1	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	24609000	usd
CY2023Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	27062000	usd
CY2024Q1	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	20593000	usd
CY2023Q4	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	22639000	usd
CY2024Q1	us-gaap	Long Term Debt LongTermDebt	1124798000	usd
CY2023Q4	us-gaap	Long Term Debt LongTermDebt	1150299000	usd
CY2024Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	120000000	usd
CY2023Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	120000000	usd
CY2024Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1004798000	usd
CY2023Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1030299000	usd
CY2023Q4	us-gaap	Capitalized Exploratory Well Costs CapitalizedExploratoryWellCosts	40888000	usd
CY2024Q1	us-gaap	Capitalized Exploratory Well Cost Additions Pending Determination Of Proved Reserves CapitalizedExploratoryWellCostAdditionsPendingDeterminationOfProvedReserves	25818000	usd
CY2024Q1	us-gaap	Reclassification To Well Facilities And Equipment Based On Determination Of Proved Reserves ReclassificationToWellFacilitiesAndEquipmentBasedOnDeterminationOfProvedReserves	41299000	usd
CY2024Q1	us-gaap	Capitalized Exploratory Well Cost Charged To Expense1 CapitalizedExploratoryWellCostChargedToExpense1	229000	usd
CY2024Q1	us-gaap	Capitalized Exploratory Well Costs CapitalizedExploratoryWellCosts	25178000	usd
CY2024Q1	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	24609000	usd
CY2023Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	27062000	usd
CY2024Q1	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	20593000	usd
CY2023Q4	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	22639000	usd
CY2024Q1	us-gaap	Long Term Debt LongTermDebt	1124798000	usd
CY2023Q4	us-gaap	Long Term Debt LongTermDebt	1150299000	usd
CY2024Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	120000000	usd
CY2023Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1030299000	usd
CY2023Q4	us-gaap	Asset Retirement Obligation AssetRetirementObligation	13245000	usd
CY2024Q1	us-gaap	Asset Retirement Obligation Liabilities Incurred AssetRetirementObligationLiabilitiesIncurred	201000	usd
CY2024Q1	us-gaap	Asset Retirement Obligation Accretion Expense AssetRetirementObligationAccretionExpense	239000	usd
CY2024Q1	us-gaap	Asset Retirement Obligation AssetRetirementObligation	13685000	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	11517228
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	12.2
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y10M24D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	128429000	usd
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	1949000
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	10.5
CY2023	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	11834
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	12.52
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	5333
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	24.83
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	13449061
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	11.95
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y3M18D
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	47672000	usd
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	3333
CY2024Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	29.67
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	13445728
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	11.95
CY2024Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y1M6D
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	65821000	usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	13387074
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	11.88
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P6Y3M18D
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	47672000	usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	11438074
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue	40383000	usd
CY2023Q4	us-gaap	Asset Retirement Obligation AssetRetirementObligation	13245000	usd
CY2024Q1	us-gaap	Asset Retirement Obligation Liabilities Incurred AssetRetirementObligationLiabilitiesIncurred	201000	usd
CY2024Q1	us-gaap	Asset Retirement Obligation Accretion Expense AssetRetirementObligationAccretionExpense	239000	usd
CY2024Q1	us-gaap	Asset Retirement Obligation AssetRetirementObligation	13685000	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	11517228
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	12.2
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y10M24D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	128429000	usd
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	1949000
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	10.5
CY2023	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	11834
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	12.52
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	5333
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	24.83
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	13449061
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	11.95
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y3M18D
CY2024Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	29.67
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	13445728
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	11.95
CY2024Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y1M6D
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	65821000	usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	13387074
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	11.88
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P6Y3M18D
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	47672000	usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	11438074
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice	12.12
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P6Y10M24D
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue	40383000	usd
CY2023Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	14507000	usd
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2297000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	14507000	usd
CY2023Q1	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	13600000	usd
CY2024Q1	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount	377000	usd
CY2023Q1	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount	289000	usd
CY2023Q1	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount	289000	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	13387074
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	11.88
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P6Y1M6D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	65821000	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	11438074
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice	12.12
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P6Y8M12D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue	55550000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	414000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	14000	usd
CY2024Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	400000	usd
CY2024Q1	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	386000	usd
CY2024Q1	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	223000	usd
CY2023Q1	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	0	usd
CY2024Q1	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	609000	usd
CY2023Q1	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	0	usd
CY2024Q1	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	1465000	usd
CY2023Q1	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	13920000	usd
CY2024Q1	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	223000	usd
CY2023Q1	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	587000	usd
CY2024Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	1688000	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	13387074
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P6Y1M6D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	11438074
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	414000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	14000	usd
CY2024Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	400000	usd
CY2023Q1	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	0	usd
CY2023Q1	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	0	usd
CY2024Q1	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	1465000	usd
CY2023Q1	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	13920000	usd
CY2024Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	1688000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	14507000	usd
CY2024Q1	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	1834000	usd
CY2023Q1	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	13600000	usd
CY2024Q1	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount	377000	usd
CY2024Q1	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	399000	usd
CY2023Q1	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	587000	usd
CY2024Q1	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	-313000	usd
CY2023Q1	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	31000	usd
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2297000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	14507000	usd
CY2024Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.263	pure
CY2023Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.224	pure
CY2024Q1	us-gaap	Deferred Tax Asset Interest Carryforward DeferredTaxAssetInterestCarryforward	48716000	usd
CY2023Q4	us-gaap	Deferred Tax Asset Interest Carryforward DeferredTaxAssetInterestCarryforward	41352000	usd
CY2024Q1	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	11960000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	13503000	usd
CY2024Q1	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	6753000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	6332000	usd
CY2024Q1	us-gaap	Deferred Tax Assets Derivative Instruments DeferredTaxAssetsDerivativeInstruments	2909000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Derivative Instruments DeferredTaxAssetsDerivativeInstruments	0	usd
CY2024Q1	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	237000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	36000	usd
CY2024Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	0	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	0	usd
CY2024Q1	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	70575000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	61223000	usd
CY2024Q1	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	269332000	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	250859000	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Derivatives DeferredTaxLiabilitiesDerivatives	7432000	usd
CY2024Q1	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	269332000	usd
CY2023Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	258291000	usd
CY2024Q1	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	198757000	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	197068000	usd
CY2024Q1	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	45619000	usd
CY2024Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	5834000	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	45694000	usd
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	125696000
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	111055000
CY2024Q1	hpk	Incremental Common Shares Attributable To Share Based Payment Arrangements And Warrants IncrementalCommonSharesAttributableToShareBasedPaymentArrangementsAndWarrants	1786000
CY2023Q1	hpk	Incremental Common Shares Attributable To Share Based Payment Arrangements And Warrants IncrementalCommonSharesAttributableToShareBasedPaymentArrangementsAndWarrants	4588000
CY2024Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	2159000
CY2023Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	2122000
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	129641000
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	117765000
CY2023Q1	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	587000	usd
CY2024Q1	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	-313000	usd
CY2023Q1	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	31000	usd
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2297000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	14507000	usd
CY2024Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.263	pure
CY2023Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.224	pure
CY2024Q1	us-gaap	Deferred Tax Asset Interest Carryforward DeferredTaxAssetInterestCarryforward	48716000	usd
CY2023Q4	us-gaap	Deferred Tax Asset Interest Carryforward DeferredTaxAssetInterestCarryforward	41352000	usd
CY2024Q1	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	11960000	usd
CY2024Q1	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	6753000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	6332000	usd
CY2024Q1	us-gaap	Deferred Tax Assets Derivative Instruments DeferredTaxAssetsDerivativeInstruments	2909000	usd
CY2024Q1	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	237000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	36000	usd
CY2024Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	0	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	0	usd
CY2024Q1	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	70575000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	61223000	usd
CY2024Q1	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	269332000	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	250859000	usd
CY2024Q1	us-gaap	Deferred Tax Liabilities Derivatives DeferredTaxLiabilitiesDerivatives	-0	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Derivatives DeferredTaxLiabilitiesDerivatives	7432000	usd
CY2024Q1	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	269332000	usd
CY2023Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	258291000	usd
CY2024Q1	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	198757000	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	197068000	usd
CY2024Q1	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	6438000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	50257000	usd
CY2024Q1	us-gaap	Participating Securities Distributed And Undistributed Earnings Loss Basic ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic	605000	usd
CY2023Q1	us-gaap	Participating Securities Distributed And Undistributed Earnings Loss Basic ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic	4638000	usd
CY2024Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	5833000	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	45619000	usd
CY2024Q1	us-gaap	Dilutive Securities DilutiveSecurities	1000	usd
CY2023Q1	us-gaap	Dilutive Securities DilutiveSecurities	75000	usd
CY2024Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	5834000	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	45694000	usd
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	125696000
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	111055000
CY2024Q1	hpk	Incremental Common Shares Attributable To Share Based Payment Arrangements And Warrants IncrementalCommonSharesAttributableToShareBasedPaymentArrangementsAndWarrants	1786000
CY2023Q1	hpk	Incremental Common Shares Attributable To Share Based Payment Arrangements And Warrants IncrementalCommonSharesAttributableToShareBasedPaymentArrangementsAndWarrants	4588000
CY2024Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	2159000
CY2023Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	2122000
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	129641000
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	117765000
CY2023Q1	hpk	Stock Issued During Period Shares Warrants And Stock Options Exercised StockIssuedDuringPeriodSharesWarrantsAndStockOptionsExercised	11984
CY2023Q1	hpk	Stock Issued During Period Shares Warrant Exercises StockIssuedDuringPeriodSharesWarrantExercises	150
CY2024Q1	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	86000	usd
CY2023Q1	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	53000	usd
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	127855383
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	128420923
CY2024Q1	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	7934977
CY2023Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	7934977
CY2023Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	11.5
CY2023Q1	hpk	Stock Issued During Period Shares Warrants And Stock Options Exercised StockIssuedDuringPeriodSharesWarrantsAndStockOptionsExercised	11984
CY2023Q1	hpk	Stock Issued During Period Shares Warrant Exercises StockIssuedDuringPeriodSharesWarrantExercises	150
CY2023Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	11834
CY2024Q1	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	86000	usd
CY2023Q1	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	53000	usd
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	127855383
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	128420923
CY2024Q1	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	7934977
CY2023Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	7934977
CY2024Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	11.5
CY2023Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	11.5

Files In Submission

Name	View Source	Status
0001437749-24-015355-index-headers.html	Edgar Link	pending
0001437749-24-015355-index.html	Edgar Link	pending
0001437749-24-015355.txt	Edgar Link	pending
0001437749-24-015355-xbrl.zip	Edgar Link	pending
ex_660597.htm	Edgar Link	pending
ex_660598.htm	Edgar Link	pending
ex_660599.htm	Edgar Link	pending
ex_660600.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
hpe20240331_10q.htm	Edgar Link	pending
hpk-20240331.xsd	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
hpk-20240331_cal.xml	Edgar Link	unprocessable
hpk-20240331_def.xml	Edgar Link	unprocessable
hpk-20240331_lab.xml	Edgar Link	unprocessable
hpk-20240331_pre.xml	Edgar Link	unprocessable
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
hpe20240331_10q_htm.xml	Edgar Link	completed

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$HPK
HighPeak Energy, Inc. Stock $hpk

2024 Q2 Form 10-Q Financial Statement

#000143774924015355 Filed on May 08, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$HPK HighPeak Energy, Inc. Stock $hpk

2024 Q2 Form 10-Q Financial Statement

#000143774924015355 Filed on May 08, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$HPK
HighPeak Energy, Inc. Stock $hpk